SCHEMBL24569030

SCHEMBL24569030

Cc1cc(-c2cc(Cl)ccc2F)nc(Cl)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 5/20 0.38
TGFBR1 P36897 5/20 0.37
ALOX5 P09917 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
IDO1 P14902 1/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2C8 P10632 1/20 0.36
SLC22A1 O15245 1/20 0.36
ABCB11 O95342 1/20 0.36
DRD3 P35462 1/20 0.36
OPRK1 P41145 1/20 0.36
PDE4D Q08499 1/20 0.36
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
PTGES O14684 1/20 0.35
HSD11B1 P28845 1/20 0.35
LRRK2 Q5S007 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24568805 0.86 AGPAT2 (0.41) AGPAT2TGFBR1CYP3A4CYP2C8HSP90AA1
SCHEMBL24569039 0.83 TGFBR1 (0.36) AGPAT2TGFBR1IDO1CYP3A4HSP90AA1
SCHEMBL27030857 0.81 CXCL12 (0.38) AGPAT2TGFBR1CYP3A4SLC22A1ABCB11
SCHEMBL24568079 0.81 S1PR4 (0.43)
SCHEMBL27200492 0.79 TGFBR1 (0.47) TGFBR1CYP3A4CYP1A2
SCHEMBL24568790 0.77 HPGD (0.44) AGPAT2IDO1CYP3A4HSP90AA1KMO
SCHEMBL24568794 0.76 CYP11B1 (0.45) TGFBR1CYP3A4CYP1A2
SCHEMBL30412900 0.74 TGFBR1 (0.63) AGPAT2TGFBR1CYP3A4CYP2C8CYP1A2
SCHEMBL24568795 0.73 PTGES (0.31) PTGES
SCHEMBL24569028 0.73 HSP90AA1 (0.40) AGPAT2TGFBR1PDE4DHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136221-A1 PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-30 WO disclosed